Clinical Value of Tryptase Expression by Myeloblasts and Serum Transforming Growth Factor-Beta in Patients with Acute Myeloblastic Leukemia
Osama Hassan Mahmoud;
Abstract
Acute myeloid leukemia (AML) is a clonal, malignant disease of hemopoietic tissue resulting from somatic mutation in a pleuripotent cell or a slightly more differentiated progenitor cell and is characterized by the proliferation of abnormal leukemic cells
Other data
| Title | Clinical Value of Tryptase Expression by Myeloblasts and Serum Transforming Growth Factor-Beta in Patients with Acute Myeloblastic Leukemia | Other Titles | القيمة الإكلينيكية لإظهار إنزيم التربتاز بخلايا البلاست النقوية و معامل النمو-بيتا بمصل الدم لمرضى سرطان الدم النقوى الحاد | Authors | Osama Hassan Mahmoud | Keywords | Clinical Value of Tryptase Expression by Myeloblasts and Serum Transforming Growth Factor-Beta in Patients with Acute Myeloblastic Leukemia | Issue Date | 2010 | Description | Acute myeloid leukemia (AML) is a clonal, malignant disease of hemopoietic tissue resulting from somatic mutation in a pleuripotent cell or a slightly more differentiated progenitor cell and is characterized by the proliferation of abnormal leukemic cells |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.